Board Member
Board member since
2021
Nationality
Danish
Born
1968
Non-independent
Board committees, LEO Pharma
Member of the Audit Committee, the Remuneration and Nomination Committee and the Innovation Committee.
Positions and management duties
CEO of the LEO Foundation and LEO Holding A/S. Chair of LH Capital A/S and House of Denmark A/S. Board member of the World Diabetes Foundation.
Career
Former CFO of Novo Holdings A/S and, prior to this, held various leadership roles at Novo Nordisk A/S, including Head of Investor Relations. Earlier career as an equity analyst. Former vice chair of NNIT A/S and chair of Fondsmæglerselskabet Stockrate Asset Management A/S.
Special competencies
Extensive international experience in strategy, business development, financial planning, investor relations and leadership at Novo Nordisk A/S. Led the risk and capital allocation committee, developed the investment strategy and implemented efficiency programs at Novo Holdings A/S. Managed foundation initiatives and business development at the LEO Foundation and LEO Holding A/S. Skilled in risk management, governance, investor relations and global financial oversight.
Meet our Board of Directors
The Board of Directors is accountable for LEO Pharma’s corporate governance, strategic direction, and long-term sustainability.
